Skip to main content
ADVANCED SEARCH
Log in
Top
Journal of Neurology
Published in:

01-05-2025 | Parkinson Disease | Correction

Correction: Plasma alpha-synuclein predicts cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis

Authors: Ziyue Zhu, Dennis Cordato, Renfen Chen, Ying Hua Xu, Boaz Shulruf, Daniel Kam Yin Chan

Published in: Journal of Neurology | Issue 5/2025

Login to get access
Metadata
Title
Correction: Plasma alpha-synuclein predicts cognitive impairment in Parkinson’s disease: a systematic review and meta-analysis
Authors
Ziyue Zhu
Dennis Cordato
Renfen Chen
Ying Hua Xu
Boaz Shulruf
Daniel Kam Yin Chan
Publication date
01-05-2025
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 5/2025
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-025-13021-3

Other articles of this Issue 5/2025

Pathological laugher and crying in motor neuron diseases: a matter of bulbar and neurobehavioral involvement with sex imbalance

Keeping an eye on Parkinson disease

Prodromal seizures in anti-MOG and anti-CASPR2 antibody co-positivity: a case report

Aging and the neuropsychiatry of multiple sclerosis: a cross-sectional study

Successful treatment of morvan syndrome with efgartigimod: report of two cases

Association between weather conditions and migraine: a systematic review and meta-analysis

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest
Image Credits